Polio-rhinovirus promising for malignant glioma patients
(HealthDay)—Intratumoral infusion of recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO) can be delivered safely and is tied to higher survival rates than those of historical controls, according to a study published ...
Jul 12, 2018
0
0